ECM
DVAX

Everence Capital Management’s Dynavax Technologies DVAX Stock Holding History

Everence Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,100
Closed -$224K – 881
2024
Q3 		$224K Hold
20,100
– – 0.01% 689
2024
Q2 		$229 Hold
20,100
– – 0.02% 638
2024
Q1 		$249 Hold
20,100
– – 0.02% 635
2023
Q4 		$281K Hold
20,100
– – 0.02% 573
2023
Q3 		$297 Hold
20,100
– – 0.02% 554
2023
Q2 		$230K Hold
20,100
– – 0.02% 606
2023
Q1 		$197 Hold
20,100
– – 0.02% 690
2022
Q4 		$214 Hold
20,100
– – 0.02% 676
2022
Q3 		$210K Hold
20,100
– – 0.02% 638
2022
Q2 		$253K Buy
+20,100
New +$214K 0.02% 568

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Everence Capital Management's DVAX Position: Q4 2024 in Review

Everence Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2024, closing a stake of 20,100 shares — an estimated $224K sold.

Everence Capital Management first reported a position in DVAX in Q2 2022 and held it in 10 quarters. The position peaked at $281K in Q4 2023. 256 funds tracked by Wall St. Rank hold DVAX as of Q4 2024.

  • Everence Capital Management reported no remaining Dynavax Technologies position as of Q4 2024 after selling out during the quarter.
  • Everence Capital Management sold 20,100 Dynavax Technologies shares in Q4 2024, an estimated $224K.
  • Everence Capital Management first reported a position in Dynavax Technologies in Q2 2022 and held it in 10 quarters.
  • Everence Capital Management's Dynavax Technologies position peaked at $281K in Q4 2023.
  • 256 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.